Acrux Limited 公司資料 |
|
Acrux is a specialty pharmaceutical company, developing and commercialising a range of patented, patient-preferred healthcare products for global markets, using its innovative technology to administer drugs through the skin. Acrux's product pipeline includes treatments of hormonal deficiencies, pain, central nervous system disorders and a contraceptive. Acrux has also licensed its technology to Eli Lilly for veterinary healthcare products.
|
|
Key Developments: Acrux Limited
 |
6月22日澳洲股市：打破跌勢
JUNE 22, 2009 13:00 - Article Views: 8,685
上週五，澳洲股市在一周之中首次收漲。基本指數S&P/ASX200上漲7.5點,或0.19%,報3,899.6點,綜合指數上漲7點,或0.18%,報3894.4點。 |
 |
11,346 公司背景瀏覽 |
|
本頁瀏覽人次: (過去7日: 11) (過去30日: 44) (自發布以來: 2026)
|
|
|
|
ASX S&P200
ASX:ACR
